We are live on
!
Find out more
FGP
Freestone Grove Partners Portfolio holdings
AUM
$14.2B
1-Year Est. Return
24.58%
This Fund
S&P 500
This Quarter
Est. Return
+2.04%
1 Year Est. Return
+24.58%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$8.16B
AUM Growth
–
Cap. Flow
+$8.32B
Cap. Flow
% of AUM
101.89%
Top 10 Holdings %
Top 10 Hldgs %
19.11%
Holding
569
New
569
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$694M |
| 2 |
ExxonMobil
XOM
|
+$113M |
| 3 |
ConocoPhillips
COP
|
+$105M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$103M |
| 5 |
Becton Dickinson
BDX
|
+$101M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.73% |
| 2 | Financials | 16.49% |
| 3 | Industrials | 13.44% |
| 4 | Healthcare | 12.86% |
| 5 | Energy | 10.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
376
Match Group
MTCH
$8.99B
| $510K | 0.01% |
+15,587
| New | +$534K |
|
377
Taylor Morrison
TMHC
$6.67B
| $510K | 0.01% |
+8,328
| New | +$568K |
|
378
Landstar System
LSTR
$6.84B
| $502K | 0.01% |
+2,922
| New | +$534K |
|
379
Arcutis Biotherapeutics
ARQT
$3.39B
| $499K | 0.01% |
+35,818
| New | +$392K |
|
380
Cintas
CTAS
$82.3B
| $492K | 0.01% |
+2,694
| New | +$566K |
|
381
Varonis Systems
VRNS
$5.3B
| $482K | 0.01% |
+10,852
| New | +$564K |
|
382
Pfizer
PFE
$140B
| $481K | 0.01% |
+18,134
| New | +$492K |
|
383
Americold
COLD
$4.05B
| $479K | 0.01% |
+22,404
| New | +$542K |
|
|
RDFN
384
DELISTED
Redfin
RDFN
| $474K | 0.01% |
+60,200
| New | +$584K |
|
385
Kirby Corp
KEX
$7.99B
| $472K | 0.01% |
+4,458
| New | +$537K |
|
386
United Parks & Resorts
PRKS
$2.14B
| $471K | 0.01% |
+8,386
| New | +$459K |
|
387
Camping World
CWH
$368M
| $468K | 0.01% |
+22,221
| New | +$506K |
|
388
La-Z-Boy
LZB
$1.59B
| $463K | 0.01% |
+10,636
| New | +$449K |
|
389
Korn Ferry
KFY
$4.04B
| $457K | 0.01% |
+6,776
| New | +$493K |
|
390
Federal Signal
FSS
$7.29B
| $450K | 0.01% |
+4,867
| New | +$447K |
|
391
Sensata Technologies
ST
$6.71B
| $449K | 0.01% |
+16,397
| New | +$532K |
|
392
Winnebago Industries
WGO
$879M
| $449K | 0.01% |
+9,395
| New | +$532K |
|
393
Dow Inc
DOW
$21.4B
| $447K | 0.01% |
+11,141
| New | +$520K |
|
394
Incyte
INCY
$23.5B
| $446K | 0.01% |
+6,462
| New | +$460K |
|
395
GeneDx Holdings
WGS
$1.86B
| $445K | 0.01% |
+5,791
| New | +$405K |
|
396
Travere Therapeutics
TVTX
$5.32B
| $445K | 0.01% |
+25,521
| New | +$451K |
|
397
LGI Homes
LGIH
$1.4B
| $443K | 0.01% |
+4,959
| New | +$521K |
|
398
Tarsus Pharmaceuticals
TARS
$2.54B
| $439K | 0.01% |
+7,921
| New | +$360K |
|
399
PPG Industries
PPG
$26.2B
| $438K | 0.01% |
+3,663
| New | +$458K |
|
400
Northern Trust
NTRS
$22.2B
| $437K | 0.01% |
+4,262
| New | +$436K |
|
Similar funds
BIP
SSA
X
CM
BBVA
IFP
TI
Freestone Grove Partners's Q4 2024 Portfolio in Review
Q4 2024 is the first quarter with a 13F filing on record for Freestone Grove Partners, which disclosed 569 positions worth $8.16B. Its ten largest holdings account for 19% of the portfolio.
Its largest position is iShares Core S&P 500 ETF: 1,173,000 shares worth $691M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, followed by Financials and Industrials.
- Freestone Grove Partners's largest Q4 2024 buy was iShares Core S&P 500 ETF: 1,173,000 shares worth $691M.
- Freestone Grove Partners's ten largest holdings make up 19% of its $8.16B portfolio in Q4 2024.
- Freestone Grove Partners disclosed 569 positions in Q4 2024, its first 13F filing on record.
Based on Freestone Grove Partners's 13F filing for Q4 2024, filed 14 Feb 2025.